Aptevo Therapeutics Stock Price on January 30, 2025

APVO Stock  USD 3.26  0.19  5.51%   
Below is the normalized historical share price chart for Aptevo Therapeutics extending back to July 20, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aptevo Therapeutics stands at 3.26, as last reported on the 20th of February, with the highest price reaching 3.26 and the lowest price hitting 3.26 during the day.
IPO Date
20th of July 2016
200 Day MA
13.2859
50 Day MA
5.1495
Beta
5.092
 
Covid
If you're considering investing in Aptevo Stock, it is important to understand the factors that can impact its price. Aptevo Therapeutics secures Sharpe Ratio (or Efficiency) of -0.18, which signifies that the company had a -0.18 % return per unit of risk over the last 3 months. Aptevo Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aptevo Therapeutics' Risk Adjusted Performance of (0.07), standard deviation of 9.36, and Mean Deviation of 6.07 to double-check the risk estimate we provide.
  
At this time, Aptevo Therapeutics' Common Stock Shares Outstanding is very stable compared to the past year. As of the 20th of February 2025, Stock Based Compensation is likely to grow to about 1.6 M, while Total Stockholder Equity is likely to drop about 4.5 M. . As of the 20th of February 2025, Price To Sales Ratio is likely to drop to 4.17. In addition to that, Price Earnings Ratio is likely to drop to -0.05. Aptevo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1754

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsAPVO

Estimated Market Risk

 8.91
  actual daily
79
79% of assets are less volatile

Expected Return

 -1.56
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.18
  actual daily
0
Most of other assets perform better
Based on monthly moving average Aptevo Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptevo Therapeutics by adding Aptevo Therapeutics to a well-diversified portfolio.
Price Book
1.0704
Enterprise Value Ebitda
0.3863
Price Sales
1.6074
Shares Float
1.5 M
Wall Street Target Price
21

Related Headline

Achilles Therapeutics Headline on 30th of January 2025

Achilles Therapeutics plc saw a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 122,300 shares, an increase of 35.4 percent from the December 31st total of 90,300 shares. Based on an average daily volume of 169,400 shares, the days-to-cover ratio

Aptevo Therapeutics Valuation on January 30, 2025

It is possible to determine the worth of Aptevo Therapeutics on a given historical date. On January 30, 2025 Aptevo was worth 4.42 at the beginning of the trading date compared to the closed value of 4.46. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aptevo Therapeutics stock. Still, in general, we apply an absolute valuation method to find Aptevo Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aptevo Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aptevo Therapeutics' related companies.
 Open High Low Close Volume
  4.46    4.57    4.29    4.31    32,068  
01/30/2025
  4.42    4.64    4.29    4.46    38,419  
  4.46    4.49    4.33    4.38    10,511  
Backtest Aptevo Therapeutics  |  Aptevo Therapeutics History  |  Aptevo Therapeutics Valuation PreviousNext  
Open Value
4.42
4.46
Closing Value
31.15
Upside

Aptevo Therapeutics Trading Date Momentum on January 30, 2025

On January 31 2025 Aptevo Therapeutics was traded for  4.38  at the closing time. The top price for the day was 4.49  and the lowest listed price was  4.33 . The trading volume for the day was 10.5 K. The trading history from January 31, 2025 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.79% . The overall trading delta against the current closing price is 8.74% .
JavaScript chart by amCharts 3.21.1501/30/2025Jan 21Jan 23Jan 25Jan 27Jan 29Jan 31FebFeb 04Feb 064.04.14.24.34.44.54.64.7

Aptevo Therapeutics Fundamentals Correlations and Trends

By evaluating Aptevo Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aptevo Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aptevo financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Aptevo Therapeutics Stock history

Aptevo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aptevo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aptevo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aptevo Therapeutics stock prices may prove useful in developing a viable investing in Aptevo Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding285 K299.2 K
Net Income Applicable To Common Shares9.2 M9.7 M

Aptevo Therapeutics Quarterly Net Working Capital

4.45 Million

Aptevo Therapeutics Stock Technical Analysis

Aptevo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aptevo Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aptevo Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Aptevo Therapeutics Period Price Range

Low
February 20, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Aptevo Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Aptevo Therapeutics February 20, 2025 Market Strength

Market strength indicators help investors to evaluate how Aptevo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aptevo Therapeutics shares will generate the highest return on investment. By undertsting and applying Aptevo Therapeutics stock market strength indicators, traders can identify Aptevo Therapeutics entry and exit signals to maximize returns

Aptevo Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Aptevo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aptevo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aptevo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Aptevo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptevo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptevo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptevo Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptevo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptevo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(87.38)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.76)
Return On Equity
(2.84)
The market value of Aptevo Therapeutics is measured differently than its book value, which is the value of Aptevo that is recorded on the company's balance sheet. Investors also form their own opinion of Aptevo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aptevo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptevo Therapeutics' market value can be influenced by many factors that don't directly affect Aptevo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptevo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptevo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptevo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.